Paul Christopher Williams - Feb 20, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
Feb 20, 2024
Transactions value $
-$3,285
Form type
4
Date filed
2/22/2024, 05:49 PM
Previous filing
Nov 21, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +1.01K +25.44% 4.96K Feb 20, 2024 Direct F1
transaction CTKB Common Stock Tax liability -$3.28K -392 -7.9% $8.38 4.57K Feb 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -1.01K -8.33% $0.00 11.1K Feb 20, 2024 Common Stock 1.01K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on February 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and 3/48 of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on February 18, May 18, August 18 and November 18.